David Knechtel is the Vice President and General Manager at argenx, leading the launch of efgartigimod in Europe. With extensive experience in pharmaceutical companies like Otsuka and Johnson & Johnson across Europe and the UK, David has a strong background in sales, marketing, and business development. David holds an MBA from Duke University, emphasizing in Health Sector Management.
This person is not in any offices